The long-term clinical outcome of myasthenia gravis in patients with thymoma
The long-term clinical outcome of myasthenia gravis in patients with thymoma
复制标题
DOI：
10.1212/wnl.51.4.1198
复制
发表时间：
1998-10-01
期刊：
影响因子：
9.9
通讯作者：
Dhanani, A
中科院分区：
文献类型：
--
作者：
Bril, V;Kojic, J;Dhanani, A
我们用改良的Osserman分类对42例合并胸腺瘤的重症肌无力(MG)患者和42例无胸腺瘤的全身性MG患者进行了比较。诊断时、胸腺切除后6个月、5年和10年的平均Osserman分级在组间没有差异。我们的结果表明，胸腺瘤不是MG长期临床结局的负面决定因素。
We compared 42 myasthenia gravis (MG) patients with thymoma with 42 generalized MG patients without thymoma using a modified Osserman classification. The mean Osserman grades at diagnosis, 6 months, and 5 and 10 years post-thymectomy did not differ between groups. Our results indicate that thymoma is not a negative determinant for the long-term clinical outcome of MG.